Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2004

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/06/2004
Quarter2
Financial Year End31/12/2004
The figureshave not been audited

Attachments

pharma_klse0406_final.doc
287 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2004


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2004 
30/06/2003 
30/06/2004 
30/06/2003 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
178,644
155,262
369,949
309,787
2Profit/(loss) before tax
16,264
13,347
36,933
31,260
3Profit/(loss)
after tax and minority
interest
10,882
8,389
23,266
20,035
4Net profit/(loss) for
the period
10,882
8,389
23,266
20,035
5Basic earnings/(loss) per share (sen)
10.77
8.39
23.05
20.03
6Dividend per share (sen)
4.50
3.50
4.50
3.50



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

2.3800
2.2200

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Board of Directors of Pharmaniaga Berhad recommends an interim tax exempt dividend of 4.5 sen per share (2003: tax exempt dividend of 3.5 sen per share). The dates of entitlement and payment will be announced at a later date.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced6 Aug 2004  
CategoryFinancial Results
Reference NoCC-040803-62728